Kaye Scholer Announces Attorney Elevations for 2014
New York—Kaye Scholer today announced that it has elevated six counsel to partner. It also raised 10 associates to the position of counsel, which is the intermediary step for firm lawyers who wish to be on a partner track. With a total of 16 promotions, this is the largest group of lawyers to be elevated at the firm in five years. These appointments are effective as of January 1, 2014.
“Kaye Scholer strongly believes that promoting lawyers from within is the best way to strengthen and grow client relationships, maintain our collaborative culture and ensure continuity of service,” said Kaye Scholer Managing Partner Mike Solow. “At a time when law firms are promoting fewer and fewer lawyers, we are delighted to be able to elevate so many deserving attorneys this year. After a period of paring back, we are once again poised to grow the firm, and promoting so large a class is an important first step. These talented lawyers represent Kaye Scholer’s future, and we congratulate them on this milestone in their careers.”
Thirteen of the attorneys are based in Kaye Scholer’s New York office; the other three are based in the Washington, DC office, the firm’s second largest in its nine-office network. In terms of Departments, six attorneys work in Complex Commercial Litigation, three in Tax & Private Clients, two each in Corporate, Finance and National Security and one in Real Estate.
The new partners are:
Jonathan Arkins (Finance/New York) represents financial institutions in domestic and foreign asset-backed securitizations, supply chain financing, repurchase transactions, subscription lines and secured lending. He has extensive experience in the securitization of diverse asset types, including lottery, trade and equipment rental receivables. He advises both US and international financial institutions on supply chain finance structures, represents banks and borrowers/sellers alike in repurchase transactions and more traditional forms of leveraged and secured lending, and has a significant practice in private equity fund financing facilities, including subscription lines. Originally from Australia, Arkins holds an LLB and a LLM from Monash University.
Alan Glantz (Finance/New York) focuses on representing financial institutions, private equity sponsors and other corporate clients in the structuring, negotiation and documentation of a broad range of financing transactions. His experience includes domestic and cross-border acquisition financings, working capital and asset-based financings, first and second lien debt financings, mezzanine financings, high-yield debt issuances, debtor-in-possession financings, recapitalizations, restructurings and workouts. Admitted to practice in both New York and New Jersey, Glantz holds a JD from Fordham University School of Law.
Jonathan Green (Complex Commercial Litigation/New York) focuses on securities regulatory and enforcement matters, government and corporate investigations, and white collar criminal defense. Green was an Assistant US Attorney in the Eastern District of NY, where he investigated and prosecuted criminal matters involving allegations of securities fraud, money laundering, mortgage fraud, and FCPA violations, among others. Before joining the US Attorney’s Office, Green was a senior counsel at the US SEC, Division of Enforcement, NY office, where he investigated cases involving insider trading, market manipulation, fraudulent and unregistered offerings and accounting improprieties. Green obtained his JD from Seton Hall University School of Law.
Samuel Lonergan (Complex Commercial Litigation/New York) concentrates on complex commercial disputes with a focus on fraud and Deceptive Trade Practices Act (DTPA) matters and civil and criminal internal corporate investigations. He has litigated on behalf of clients in a wide range of industries, including pharmaceuticals, finance, telecommunications, aircraft, insurance, alternative energy and retail, providing practical advice that balances the client’s business needs with legal considerations. A member of Kaye Scholer’s Life Sciences group, Lonergan has represented international pharma companies in state attorney general actions pertaining to drug pricing, reimbursement and off-label marketing. He received his JD from Georgetown University Law Center.
Tiffany Moseley (Commercial Litigation/Washington, DC) has extensive experience in complex multinational litigation and investigations in diverse subject matter areas on the trial and appellate level. Her current practice focuses on complex civil and criminal litigation for both the private and public sectors in the areas of commercial contract disputes, federal regulatory and white collar investigations, intellectual property disputes and mass torts. Prior to joining Kaye Scholer, Moseley served as an AUSA for the Southern District of California, where she prosecuted federal criminal cases involving fraud, immigration offenses and narcotics trafficking. She holds a JD from University of Chicago Law School.
David Sausen (Tax & Private Clients/New York) counsels clients on tax issues related to mergers and acquisitions, partnerships and limited liability companies, investment funds, leverages leasing transactions, sovereign wealth funds, cross-border transactions and restructurings, and IRS and New York tax controversy matters. He also has considerable experience in forming and advising tax-exempt organizations on various issues including private inurement, self-dealing, unrelated business taxable income, and excess benefit transactions. Sausen also serves on the Pro Bono Committee at Kaye Scholer. A graduate of Cornell University Law School, he also earned an LLM in Taxation from NYU School of Law.
The new counsel are:
Aaron Allardyce (Real Estate/New York) has extensive experience representing investment banks and other institutional lenders in the origination and restructuring of mortgage and mezzanine loans for the acquisition and refinancing of hotels, office buildings, multi-family housing complexes and industrial facilities throughout the United States, Central America and the Caribbean. He holds a JD from NYU School of Law.
Gregg Benson (Tax & Private Clients/New York) has a broad-based tax practice covering tax issues relating to U.S. and cross border transactions and structuring, with a particular focus in mergers and acquisitions; partnerships and limited liability companies; private and public debt and equity offerings; structured finance and securitization; and renewable energy project financing. A graduate of Fordham University Law School, he received his LLM in Taxation from NYU School of Law.
Aaron Gardner (Corporate/New York) represents a variety of domestic and foreign companies, including private equity funds and publicly held and private companies in various industries. He represents clients in corporate transactions including M&A, public and private securities offerings, corporate finance, joint ventures, strategic alliances, structuring and negotiating IP licenses, marketing and distribution agreements, manufacturing and supply agreements, and other complex business relationships. He holds a JD from Brooklyn Law School.
David Hibey (National Security, Government Contracts & Regulatory Compliance/Washington, DC) focuses on government contracts matters, white collar litigation, and internal investigations involving FCPA, antitrust, securities, and off-label marketing. In the government contracts realm, Hibey provides counseling, due diligence and litigation advice. His experience includes first-chair trial and appellate work as well as preparing and accompanying witnesses, individuals and corporations before the DOJ, SEC and other agencies. A graduate of Georgetown University Law Center, Hibey previously served as a Trial Attorney for the U.S. Department of Justice's Commercial Litigation Branch.
David Menchel (Corporate/New York) advises public and private companies, including private equity firms and their portfolio companies, on international and domestic M&A transactions, joint ventures, equity investments and co-investments, securities issuances and compliance, corporate governance/takeover defense and other general corporate matters. He also has significant experience representing buyers, lenders and debtors in bankruptcy-related M&A transactions, including debt-for-equity exchanges and asset sales under the Bankruptcy Code. He holds a JD from New York University School of Law.
Daphne Morduchowitz (Complex Commercial Litigation/New York) focuses on financial services and securities litigation, white collar defense, and complex commercial litigation. She has extensive experience representing individual officers and directors of large publicly traded corporations in both federal and state courts, as well as in connection with regulatory investigations. She received her JD from New York University School of Law.
Karalyn Meany Mildorf (National Security, Government Contracts & Regulatory Compliance/Washington, DC) focuses her practice in the areas of Exon-Florio reviews before the Committee on Foreign Investment in the United States (CFIUS), foreign ownership, control or influence (FOCI) mitigation matters and export control compliance. She has represented clients in more than 100 CFIUS reviews and has extensive experience with national security requirements in connection with complex transactions, including negotiation and implementation of CFIUS and FOCI mitigation arrangements. She holds a JD from the University of Virginia School of Law.
Paula Ramer (Complex Commercial Litigation/New York) represents pharmaceutical and medical device companies in government investigations involving allegations of healthcare fraud. She conducts internal investigations and litigates cases brought under the False Claims Act and state deceptive trade practices statutes. She has developed fraud and abuse training for clients, advises companies on their compliance programs and has written on individual liability, exclusion and First Amendment issues arising from healthcare fraud prosecutions. She graduated from Georgetown University Law Center.
Alan E. Rothman (Complex Commercial Litigation/New York) focuses on product liability litigation, including the defense of pharmaceutical and medical device mass torts in federal multidistrict litigation (MDL) and coordinated state court proceedings. A member of the firm’s Life Sciences Group, his practice also includes counseling with respect to Medicare issues and he currently serves as Counsel to the firm’s Professional Ethics Committee. Rothman writes a bimonthly column on the MDL Panel (JPML) for Law 360. He holds a JD from Columbia University Law School.
Peter Wells (Tax & Private Clients/New York) represents both US and international clients with respect to wealth planning and preservation. He counsels private clients, family-owned companies and corporate fiduciaries throughout the world in connection with domestic and foreign trust and holding company structures, management succession issues and wealth transfer arrangements. He also focuses on family governance matters, such as arranging family or professional management succession and pre-immigration and expatriation planning. He received his JD from George Washington Law School.